Search for: "SANDOZ, INC."
Results 521 - 540
of 679
Sort by Relevance
|
Sort by Date
14 May 2010, 4:00 am
Karst – FDA’s recent decision to approve Sandoz Inc. [read post]
13 May 2010, 4:58 pm
Sandoz, Inc. [read post]
7 May 2010, 11:11 am
See Genentech, Inc. v. [read post]
6 May 2010, 4:12 pm
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
5 May 2010, 4:46 am
SmithKline Beecham plc & Anor v Sandoz AG & Anor (Afro-IP) Cenestin (conjugated estrogens)– US: Patent infringement suit in response to Para IV challenge: Teva Women's Health, Inc. v. [read post]
22 Apr 2010, 5:02 am
., Inc., 594 F.3d 419, 420 (5th Cir. 2010). [read post]
15 Apr 2010, 9:20 am
Matkari, 7 F.3d 1130, 1139 (4th Cir. 1993); Sandoz Pharmaceuticals Corp. v. [read post]
15 Apr 2010, 4:27 am
Sandoz B.V. [read post]
8 Apr 2010, 9:48 am
Sandoz Pharmaceuticals Corp., 131 F. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
4 Apr 2010, 9:55 pm
Sandoz Inc. 2:10-cv-01625; filed March 30, 2010... [read post]
22 Mar 2010, 4:13 am
Sandoz Pharmaceuticals Corp., 244 F.Supp.2d 434, 532 (W.D.Pa. 2003); Conde v. [read post]
15 Mar 2010, 2:09 pm
Sandoz Pharm. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
27 Feb 2010, 4:59 pm
Sandoz, Inc., 566 F.3d 1282, 1288 (Fed. [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
24 Feb 2010, 2:11 am
(IP Watch) Exploring a new angle in the TRIPS and drug patents debate (Spicy IP) EPO Enlarged Board of Appeal rules on patenting a method of treatment by surgery: G1/07 (IPKat) (EPLAW) (Patent Baristas) EPO Enlarged Board of Appeal decides on dosage regime – Swiss-type claims no longer available: G 2/08 – Dosage Regime/Abbot Respiratory (EPLAW) (Managing Intellectual Property) (IPKat) (Patent Baristas) India: Victory for access to medicines as Bayer loses lawsuit in India (GenericsWeb)… [read post]
22 Feb 2010, 8:41 am
Eon Labs is a subsidiary of Sandoz Inc., which is in turn a subsidiary of Novartis AG. [read post]
22 Feb 2010, 3:40 am
DOJ announced on February 22 that Eon Labs, Inc., a subsidiary of Sandoz, is paying $3.5 million to settle False Claims Act allegations regarding its statements concerning the regulatory status of nitroglycerin sustained release tablets. [read post]
